Suppr超能文献

成功治疗垂体巨大症。

Successful treatment of pituitary gigantism.

机构信息

Endocrinology, Centro Hospitalar de Lisboa Ocidental EPE Hospital de Egas Moniz, Lisboa, Portugal

Endocrinology, Centro Hospitalar de Lisboa Ocidental EPE Hospital de Egas Moniz, Lisboa, Portugal.

出版信息

BMJ Case Rep. 2021 Dec 31;14(12):e247989. doi: 10.1136/bcr-2021-247989.

Abstract

Pituitary gigantism is extremely rare, resulting from excessive secretion of growth hormone (GH) before fusion of epiphysial growth plates. We report a case of a 13-year-old boy, who presented with increased statural growth and headaches since the age of 10 years. On physical examination, his height was 180.7 cm (+3.3 SD) and Tanner stage V. Investigation revealed increased levels of serum age-adjusted and sex-adjusted insulin-like growth factor 1 (IGF-1) and failure of GH suppression during an oral glucose tolerance test (OGTT). MRI of the sellar region revealed a pituitary macroadenoma. He underwent transsphenoidal surgery and histopathological evaluation revealed mammosomatotropic adenoma. Three months after surgery, IGF-1 normalised, nadir GH during OGTT was less than 1 ng/mL and no residual tumour was found on the MRI. Genetic testing identified a mutation in the gene. This case emphasises the importance of early diagnosis of gigantism, as treatment delay increases long-term morbidity.

摘要

垂体性巨人症极为罕见,是由于生长激素(GH)在骺板融合之前过度分泌所致。我们报告了 1 例 13 岁男孩的病例,他自 10 岁起出现身高增长过快和头痛。体格检查发现,他的身高为 180.7cm(+3.3SD),Tanner 分期为 V 期。检查显示血清年龄和性别调整的胰岛素样生长因子 1(IGF-1)水平升高,口服葡萄糖耐量试验(OGTT)期间 GH 抑制失败。鞍区 MRI 显示垂体大腺瘤。他接受了经蝶窦手术,组织病理学评估显示为催乳生长激素腺瘤。手术后 3 个月,IGF-1 恢复正常,OGTT 时 GH 谷值<1ng/mL,MRI 上未发现残留肿瘤。基因检测发现了 基因的突变。该病例强调了巨人症早期诊断的重要性,因为治疗延迟会增加长期发病率。

相似文献

1
Successful treatment of pituitary gigantism.成功治疗垂体巨大症。
BMJ Case Rep. 2021 Dec 31;14(12):e247989. doi: 10.1136/bcr-2021-247989.
2
Gigantism caused by growth hormone secreting pituitary adenoma.由分泌生长激素的垂体腺瘤引起的巨人症。
Ann Pediatr Endocrinol Metab. 2014 Jun;19(2):96-9. doi: 10.6065/apem.2014.19.2.96. Epub 2014 Jun 30.
8
Pituitary gigantism: a rare learning opportunity.垂体巨大症:难得的学习机会。
Arch Dis Child Educ Pract Ed. 2020 Apr;105(2):111-116. doi: 10.1136/archdischild-2018-316282. Epub 2019 Apr 4.

本文引用的文献

2
Pituitary gigantism: a rare learning opportunity.垂体巨大症:难得的学习机会。
Arch Dis Child Educ Pract Ed. 2020 Apr;105(2):111-116. doi: 10.1136/archdischild-2018-316282. Epub 2019 Apr 4.
4
Pituitary gigantism: a retrospective case series.垂体巨人症:一项回顾性病例系列研究。
J Pediatr Endocrinol Metab. 2016 May 1;29(5):597-602. doi: 10.1515/jpem-2015-0269.
5
The Evaluation and Management of Tall Stature.高身材的评估与管理
Horm Res Paediatr. 2016;85(5):347-52. doi: 10.1159/000443685. Epub 2016 Feb 5.
7
Acromegaly: an endocrine society clinical practice guideline.肢端肥大症:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51. doi: 10.1210/jc.2014-2700. Epub 2014 Oct 30.
8
Gigantism caused by growth hormone secreting pituitary adenoma.由分泌生长激素的垂体腺瘤引起的巨人症。
Ann Pediatr Endocrinol Metab. 2014 Jun;19(2):96-9. doi: 10.6065/apem.2014.19.2.96. Epub 2014 Jun 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验